Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) appears in 322 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 43,192,306 | 4,325,527 | 11.13% | $132,600,379.00 |
| ARK Investment Management LLC | 31 Mar, 2026 | 40,212,769 | 2,895,913 | 7.76% | $123,453,202.00 |
| State Street Corp | 31 Mar, 2026 | 28,490,638 | 3,156,750 | 12.46% | $87,466,259.00 |
| BAILLIE GIFFORD & CO | 31 Mar, 2026 | 23,675,407 | -99,565 | -0.42% | $72,683,499.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 22,759,100 | 22,759,100 | 0.00% | $69,870,437.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 22,244,387 | 22,244,387 | 0.00% | $68,290,268.00 |
| SOFTBANK GROUP CORP. | 31 Mar, 2026 | 13,636,515 | 0 | 0.00% | $41,864,101.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 12,275,084 | 1,340,832 | 12.26% | $37,692,773.00 |
| MIC Capital Management UK LLP | 31 Mar, 2026 | 9,644,032 | 0 | 0.00% | $29,607,180.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 6,065,661 | 1,662,777 | 37.77% | $18,621,579.00 |
| Data Collective IV GP, LLC | 31 Mar, 2026 | 5,941,120 | 0 | 0.00% | $18,239,238.00 |
| Lingotto Investment Management LLP | 31 Mar, 2026 | 5,881,738 | 950,681 | 19.28% | $18,056,936.00 |
| Amova Asset Management Americas, Inc. | 31 Mar, 2026 | 5,419,221 | -801,804 | -12.89% | $16,582,816.00 |
| Sumitomo Mitsui Trust Group, Inc. | 31 Mar, 2026 | 5,419,221 | -801,804 | -12.89% | $16,637,008.00 |
| UBS Group AG | 31 Mar, 2026 | 5,101,237 | 1,409,215 | 38.17% | $15,660,798.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Mar, 2026 | 4,225,277 | -170,827 | -3.89% | $12,971,600.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 4,066,315 | 991,192 | 32.23% | $12,483,587.00 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 31 Mar, 2026 | 4,023,398 | -51,821 | -1.27% | $12,351,832.00 |
| Northern Trust Corp | 31 Mar, 2026 | 3,968,411 | 528,462 | 15.36% | $12,183,022.00 |
| DCVC Opportunity Fund II GP, LLC | 31 Mar, 2026 | 3,951,141 | 0 | 0.00% | $12,130,003.00 |